Vontobel Holding
CADL icon

Vontobel Holding’s Candel Therapeutics CADL Stock Holding History

Vontobel Holding’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,000
Closed -$165K – 1100
2024
Q4 		$165K Sell
19,000
-3,000
-14% -$17.7K ﹤0.01% 1025
2024
Q3 		$152K Hold
22,000
– – ﹤0.01% 1019
2024
Q2 		$136K Buy
+22,000
New +$165K ﹤0.01% 1013
2024
Q1 		– Sell
-10,000
Closed -$14.7K – 1101
2023
Q4 		$14.7K Buy
+10,000
New +$9.71K ﹤0.01% 1094

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
HFF
Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Vontobel Holding's CADL Position: Q1 2025 in Review

Vontobel Holding sold out of Candel Therapeutics (CADL) in Q1 2025, closing a stake of 19,000 shares — an estimated $165K sold.

Vontobel Holding first reported a position in CADL in Q4 2023 and held it in 4 quarters. The position peaked at $165K in Q4 2024. 82 funds tracked by Wall St. Rank hold CADL as of Q1 2025.

  • Vontobel Holding reported no remaining Candel Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Vontobel Holding sold 19,000 Candel Therapeutics shares in Q1 2025, an estimated $165K.
  • Vontobel Holding first reported a position in Candel Therapeutics in Q4 2023 and held it in 4 quarters.
  • Vontobel Holding's Candel Therapeutics position peaked at $165K in Q4 2024.
  • 82 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2025.

Based on Vontobel Holding's 13F filing for Q1 2025, filed 28 Apr 2025.